| ²é¿´: 680 | »Ø¸´: 2 | ||
sunxing1234гæ (³õÈëÎÄ̳)
|
[ÇóÖú]
Õæ³ÏÇóÖú¹ØÓÚBPÒ©µä¸½¼þµÄÎÊÌ⣡£¡£¡--ÔÚÏßµÈ ÒÑÓÐ1È˲ÎÓë
|
|
BPÖо³£»áÓÐÕâÑùÒ»¶Î»°£ºOther detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other/unspecified impurities and/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use): K. ÎÊÌâÊÇ¡°See also 5.10¡±ÊǵÄʲôÄÚÈÝ£¿ ¹òлÐֵܽãÃã¡£¡ |
» ²ÂÄãϲ»¶
²ÄÁÏר˶322
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ085600Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
»¯Ñ§µ÷¼Á
ÒѾÓÐ17È˻ظ´
3-äåßÁà¤-4-¼×È©ºÏ³É
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
µ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ14È˻ظ´
klicking
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- ACI: 9
- Ó¦Öú: 923 (²©ºó)
- ¹ó±ö: 0.652
- ½ð±Ò: 19319.5
- É¢½ð: 30
- ºì»¨: 149
- ɳ·¢: 1
- Ìû×Ó: 2337
- ÔÚÏß: 513.3Сʱ
- ³æºÅ: 1426293
- ×¢²á: 2011-10-03
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xl_pro: ½ð±Ò+2, ¸ÐлÄãµÄÓ¦Öú£¬ÐÁ¿àÁË£¡ 2015-11-08 11:08:23
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xl_pro: ½ð±Ò+2, ¸ÐлÄãµÄÓ¦Öú£¬ÐÁ¿àÁË£¡ 2015-11-08 11:08:23
| ÕâÓ¦¸ÃÊÇָŷÖÞÒ©µäͨÔò5.10 Control of impurities in substances for pharmaceutical use |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : 5.10.pdf
2015-11-07 07:47:30, 252.35 K

2Â¥2015-11-07 07:47:34
sunxing1234
гæ (³õÈëÎÄ̳)
![]() |
3Â¥2015-11-07 10:12:39














»Ø¸´´ËÂ¥

5